To avoid system errors, if Chrome is your preferred browser, please update to the latest version of Chrome (81 or higher) or use an alternative browser.
Click here to login if you're an NAE Member
Recover Your Account Information
Download File (mp3)
Please upgrade to a newer browser.
Randy Atkins: The “computers” are made of biological molecules called R-N-A. Similar to D-N-A, they’re known for transmitting genetic information. But Christina Smolke, a Cal Tech engineer, is programming them to do more…like sense biochemical imbalances.
Christina Smolke: This R-N-A computer would take that as input, perform the computation. It would be able to say, “yes, this is a diseased cell” or “no, this is not a diseased cell. And then it could do a variety of different things.
Randy Atkins: Like calculate, and even release, the precise type and amount of medicine needed on the spot.
Christina Smolke: They’re recognizing diseased cells and then triggering the therapeutic effect only within those diseased cells.
Randy Atkins: Smolke says such targeting should reduce side effects. With the National Academy of Engineering, Randy Atkins, 103 point 5 F-M and WTOP-dot-com.
Human trials are at least five years away.